Talkmed, Sarine & Ezion: putting to rest the myth of non-performance
ONE of the criticisms commonly heard of the local stock market is that it is a perennial underperformer.
Though classified as a developed market within the MSCI Asia ex-Japan index, it tends to be lumped together with emerging markets in Asia, and this has adversely affected the market's liquidity and performance. So conventional wisdom is that it is almost impossible to find massive outperformers here, or "ten-baggers", as brokers like to call those that are the holy grail of investing.
Maybe so. For some investors, Singapore might not be as exciting as other markets, but as the saying goes, "look and ye shall find". There are actually many "ten-baggers" available if one looks hard enough.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
S&P slashes Boeing credit outlook as rating hovers above junk status
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance